Navigation Links
Oklahoma City Thunder Point Guard Russell Westbrook and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health
Date:12/16/2010

ral infection that can become serious enough to keep teens home from school, sports and other activities.  It can sometimes result in a visit to the hospital or lead to serious complications like pneumonia or even death.  Vaccination is the best protection against the spread of the influenza virus. The CDC recommends that everyone 6 months of age and older get vaccinated against influenza each year.  This year, the seasonal influenza vaccine includes the 2009 pandemic H1N1 strain, so only the seasonal influenza vaccine is needed. Vaccination begins as soon as vaccine becomes available, usually in August, and continues into spring or as long as the influenza virus is in circulation.  In most seasons, influenza virus activity peaks in February or March, so vaccination throughout the entire influenza season is beneficial and recommended.

Meningococcal Disease / Meningococcal MeningitisAlthough rare, meningococcal disease, including meningitis, is a serious, life-threatening infection that moves quickly and can lead to death within 24 to 48 hours of first symptoms.  Early symptoms may be similar to influenza, making it difficult for health-care providers to diagnose.  Currently, the CDC recommends that all preteens and teens 11 through 18 years of age be vaccinated against meningococcal disease at the earliest possible health-care visit – ideally, during the routine 11- or 12-year-old check-up.

Pertussis, Commonly Called "Whooping Cough"Pertussis is one of the most common respiratory diseases in American teens and adults. It causes a prolonged cough that can last weeks or months and can result in pneumonia or hospitalization.   Teens and adults can spread pertussis to younger children, who can develop a life-threatening pertussis infection.  The CDC recommends a single booster dose of Tdap vaccine for people 11 through 64 years of age; immunity to the pertussis vaccine decreases over time,
'/>"/>

SOURCE Society for Adolescent Health and Medicine
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
2. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
3. Quark Pharmaceuticals Appoints New Chief Medical Officer
4. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
5. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
6. AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result
7. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
8. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
9. West Pharmaceutical Services, Inc. Appoints New Director
10. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
11. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Amgen (NASDAQ: ... quarter of 2014. Key results include: , Total ... percent product sales growth driven by strong performance across ... (carfilzomib), Prolia ® (denosumab) and XGEVA ® ... to $2.37, driven by higher revenues and a significant ...
(Date:7/29/2014)... BASKING RIDGE, N.J. , July 29, 2014 /PRNewswire/ ... a biopharmaceutical company focused on the Phase 3 clinical ... first-in-class, actively controllable antithrombotic drug system, today announced that ... webcast on Tuesday, Aug. 12, 2014, at 8:30 a.m. ... and corporate highlights. Interested participants and investors ...
(Date:7/29/2014)... Minn. , July 29, 2014  EnteroMedics Inc. ... devices using neuroblocking technology to treat obesity, metabolic diseases ... host a conference call on Thursday, August 7, 2014 ... for the second quarter ended June 30, 2014 and ... Details The second quarter conference call may ...
Breaking Medicine Technology:Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3
... 24, 2012 Marking a major milestone for ... a developer of oral drug delivery systems, announced today that ... Australian Patent Office. The patent covers an important part of ... of peptides. Oramed,s portfolio now consists of one issued patent ...
... Jan. 24, 2012  LoneStar Heart Inc., based here, today ... and Mark Maciejewski to the company,s board of directors. ... the board for LoneStar Heart; Frank Ahmann, the company,s ... executive officer of Vessix Vascular, Inc.; and Eric N. ...
Cached Medicine Technology:Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 3
(Date:7/30/2014)... As a leading outpatient surgery clinic ... boasts over 50 of the best physicians across fourteen ... Health Systems’ team are Dr. Benjamin Basseri and Dr. ... , Benjamin Basseri, MD, is a board-certified gastroenterologist. He ... followed by a fellowship in Gastroenterology at UCLA Medical ...
(Date:7/30/2014)... 2014 The Independent Woman , a ... 6 free financial workshops in the Dallas area, August ... was crafted with significant input and guidance from Kim Kiyosaki, ... like more out of life. More time, more money, and ... is the key to these goals. “Money is no longer ...
(Date:7/30/2014)... 30, 2014 Running season is in ... Shoshany aims to help runners keep running. Dr Shoshany ... athletes continue training. He has recently began implementing an ... Techniques), Cold Laser Therapy, Graston technique and kinesiology taping ... , Dr Shoshany often combines chiropractic , and ...
(Date:7/30/2014)... 30, 2014 AttorneyOne.com, a recognized authority ... latest information from the FDA on snacks . ... various snacks are recalled because they contain ... contaminated with salmonella. Salmonella can cause serious, fatal infections ... it can cause abdominal pain, vomiting, nausea, diarrhea, or ...
(Date:7/30/2014)... OK (PRWEB) July 30, 2014 The ... but it’s Founders, Amber Clour and Ryan Fightmaster hope ... level. , Officially launched on July 26th of this ... real support for others living the diabetic life. ... dreams pursued and inspirations, they believe other diabetics will ...
Breaking Medicine News(10 mins):Health News:La Peer Welcomes Two New Gastroenterologists 2Health News:La Peer Welcomes Two New Gastroenterologists 3Health News:The Independent Woman Will Offer Financial Workshops Developed by Women for Women in the Dallas Area 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2
... have found a breakthrough in the treatment of breast ... of therapies.// ,According to Professor Miles Prince from ... positron emission tomography (PET) would probably change the way ... used (PET) scans to monitor breast cancer patients to ...
... UK, 40% Of Adults Cannot Manage Without Cell Phones.The ... who had conducted the research//, claimed that certain some ... cell phones. In his study on how students felt ... the behaviors displayed, closely resembled symptoms of ‘pathological gambling’. ...
... Richards marks the rapid increase in esophageal cancer cases in the ... cancer.// Only 16 % or around 2,200, of the 14,000-esophageal cancer ... years. ,There has been a 6-fold annual rise in the ... to experts. Rise in obesity cases has been the major cause. ...
... treat migraine headaches can be effective in cluster headaches ... nerves that carry pain signals, Dr. Peter Goadsby, professor ... ,Cluster headaches are not as common as migraines and ... with cluster headaches. In the final analysis 69 patients ...
... on the anvil to raise the legal age for buying cigarettes ... health for NHS Scotland has led a team of experts //who ... Executive. ,Health Minister Andy Kerr said that such a move ... "We must get a strong message across to young Scots about ...
... Association of Tamil Nadu has called for designational equality ... ,According to the association, the move will not ... will it exempt the government doctors from performing their ... association has also requested the Government to look into ...
Cached Medicine News:Health News:Aussie Doctors Claim Breakthrough in Breast Cancer Treatment 2Health News:Rise in Esophageal Cancer is emphasized by Richards’ deat 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: